Atypical mycobacterium infection following upper eyelid Müller's muscle-conjunctival resection - case report

A review of ptosis surgery techniques performed by British Oculoplastic Surgical Society members

INTRODUCTION

Involutional ptosis repair is the signature procedure of Oculoplastic surgeons, with significant variation in approach. We aimed to assess the surgical approach currently used by BOPSS members for routine involutional ptosis repair.

METHODS

A prospective 7-question survey was carried out of BOPSS members, assessing for prevalence of anterior- versus posterior-approach, bilateral simultaneous versus staged surgery, and approach to clinical photography.

RESULTS

Of the respondents (n = 73), for routine involutional ptosis repair, 66% perform predominantly anterior-approach ptosis repair, 18% perform a mix of either anterior or posterior approach depending on the patient, and 16% perform predominantly posterior-approach ptosis repair. In bilateral ptosis, most respondents (84.9%) perform bilateral simultaneous surgery in one sitting, versus performing staged surgery (15.1%). Clinical photography is routinely obtained pre-operatively by most respondents (74%). Respondents varied in time post completion of training (CCT); the largest group (35.6%) had >15 years post certificate of (CCT) experience. Approach was not associated with experience.

CONCLUSIONS

Anterior-approach ptosis repair remains the most common approach to ptosis repair in this cohort, though posterior approach is increasing in popularity. Bilateral simultaneous surgery is most often performed, though not by all surgeons. Approach does not vary with experience level.

Unveiling Ocular Manifestations in Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE) is a complex autoimmune disorder characterized by immune dysregulation and multi-organ involvement. In this concise brief review, we highlight key insights into Ocular Systemic Lupus Erythematosus (SLE), an intricate autoimmune disorder with diverse organ involvement. Emphasizing the formation of autoantibodies and immune complex deposition, we delve into the inflammation and damage affecting ocular structures. Clinical presentations, ranging from mild dry eye syndrome to severe conditions like retinal vasculitis, necessitate a comprehensive diagnostic approach, including clinical exams, serological testing, and imaging studies. Differential diagnosis involves distinguishing SLE-related ocular manifestations from other autoimmune and non-inflammatory ocular conditions. The multidisciplinary management approach, involving rheumatologists, ophthalmologists, and immunologists, tailors treatment based on ocular involvement severity, encompassing corticosteroids, immunosuppressive agents, and biologics. Follow-up is crucial for monitoring disease progression and treatment response. Future perspectives revolve around advancing molecular understanding, refining diagnostic tools, and exploring targeted therapies. Novel research areas include genetic factors, microbiome composition, and biotechnology for tailored and effective SLE ocular treatments.